Nalinie Joharatnam-Hogan

7PUBLICATIONS
59CO-AUTHORS
Predictive and prognostic markersHuman information interaction and retrievalSolid tumoursPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 26, 2022
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves.

Oskar Wysocki, Cong Zhou, Jacobo Rogado

|May 24, 2022
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital.

Rebecca J Lee, Oskar Wysocki, Cong Zhou

|Oct 04, 2021
Testing approaches to sharing trial results with participants: The Show RESPECT cluster randomised, factorial, mixed methods trial.

Annabelle South, Nalinie Joharatnam-Hogan, Cara Purvis

|Jul 09, 2021
A guideline for the outpatient management of glycaemic control in people with cancer.

Nalinie Joharatnam-Hogan, Pinkie Chambers, Ketan Dhatariya

|Feb 14, 2021
Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs.

Nalinie Joharatnam-Hogan, Leo Alexandre, James Yarmolinsky

|Dec 02, 2020
Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes-The University College London Hospital (UCLH) Experience.

Nalinie Joharatnam-Hogan, William Wilson, Kai Keen Shiu

Pageof 2

Frequent Collaborators

2 joint publications

Rohan Shotton

2 joint publications

Lasse H Jakobsen

2 joint publications

Adina E Croitoru

2 joint publications

Mark Baxter